Company news
China Regenerative Medicine International Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Supplemental announcement in relation to resignation of auditors and appointment of auditors
November 6, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 1, 2026
Resignation of auditor
October 25, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 5, 2026
Letter to Non-registered Shareholder - New Arrangements on Dissemination of Corporate Communications
September 17, 2026
Letter to Registered Shareholder - New Arrangements on Dissemination of Corporate Communications and Reply Form
September 17, 2026
Interim Report 2026
September 17, 2026
CEO Mr. Chen Chunguo Holds a Meeting with Government Official of Shaanxi Xixian New Area - Discuss the Strategic Deployment of Regenerative Medicine Industry Develop Hi-tech Cosmeceuticals Industrial Park
September 6, 2017
R&D Team of “Acornea” Invited to Share the R&D and Application Experience of the First Chinese Bio- engineered Cornea at Oxford
August 24, 2017
China Regenerative Medicine International: “Acornea” expands clinical applications Completed FDA registration
August 17, 2017
Financial Secretary of HK SAR Paul Chan Mo-po Leads Delegation on Visit to the Group Encourages to Promote the Innovative Technology Development of Regenerative Medicine
August 17, 2017
Fund Invested to Acquire U.S Cosmeceuticals Brand-Obagi
July 18, 2017